Centrus Energy announced that it has successfully completed its operational readiness reviews with the U.S. Nuclear Regulatory Commission and received NRC approval to possess uranium at the Piketon, Ohio site and introduce uranium into the cascade of centrifuges Centrus has constructed. This is a critical milestone in advancing toward production of High-Assay, Low-Enriched Uranium, or HALEU, and means that Centrus remains on track to begin production by the end of 2023.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on LEU: